Your browser doesn't support javascript.
loading
The Future of Diabetes Therapies: New Insulins and Insulin Delivery Systems, Glucagon-Like Peptide 1 Analogs, Sodium-Glucose Cotransporter Type 2 Inhibitors, and Beta Cell Replacement Therapy.
Reinhart, Jennifer M; Graves, Thomas K.
Afiliação
  • Reinhart JM; Department of Veterinary Clinical Medicine, College of Veterinary Medicine, University of Illinois Urbana-Champaign, 1008 West Hazelwood Drive, Urbana, IL 61802, USA. Electronic address: jreinha2@illinois.edu.
  • Graves TK; College of Veterinary Medicine, Midwestern University, 19555 North 59th Avenue, Glendale, AZ 85308, USA.
Vet Clin North Am Small Anim Pract ; 53(3): 675-690, 2023 May.
Article em En | MEDLINE | ID: mdl-36854632
As the prevalence of diabetes mellitus increases, so too does the number of available treatment modalities. Many diabetic therapies available in human medicine or on the horizon could hold promise in the management of small animal diabetes. However, it is important to consider how species differences in pathophysiology, management practices and goals, and lifestyle may affect the translation of such treatment modalities for veterinary use. This review article aimed to familiarize veterinarians with the more promising novel diabetic therapies and explore their possible applications in the treatment of canine and feline diabetes mellitus.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças do Gato / Diabetes Mellitus Tipo 2 / Doenças do Cão Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças do Gato / Diabetes Mellitus Tipo 2 / Doenças do Cão Idioma: En Ano de publicação: 2023 Tipo de documento: Article